<DOC>
	<DOC>NCT02066740</DOC>
	<brief_summary>The purpose of this study is to collect acute confirmatory data to evaluate technical success and acute safety of the EverFlex™ self-expanding peripheral stent with Entrust™ delivery system.</brief_summary>
	<brief_title>EverFlex™ Self-expanding Peripheral Stent With Entrust™ Delivery System Clinical Study</brief_title>
	<detailed_description />
	<mesh_term>Peripheral Arterial Disease</mesh_term>
	<mesh_term>Peripheral Vascular Diseases</mesh_term>
	<mesh_term>Menthol</mesh_term>
	<criteria>Has stenotic, restenotic (from PTA or adjunct therapy, not including stents or stent grafts), or occluded lesion(s) located in the superficial femoral artery (SFA) and/or proximal popliteal artery (PPA) suitable for primary stenting. Has undergone previous implantation of stent(s) or stent graft(s) in the target vessel.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2015</verification_date>
	<keyword>Superficial Femoral Artery</keyword>
	<keyword>Proximal Popliteal Artery</keyword>
	<keyword>Everflex</keyword>
	<keyword>Entrust</keyword>
	<keyword>stent</keyword>
</DOC>